Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.4100
-0.0100 (-2.38%)
May 22, 2026, 12:21 PM EDT
Aspira Women's Health Revenue
Aspira Women's Health had revenue of $1.97M in the quarter ending March 31, 2026, a decrease of -13.69%. This brings the company's revenue in the last twelve months to $8.90M, down -4.34% year-over-year. In the year 2025, Aspira Women's Health had annual revenue of $9.22M with 0.37% growth.
Revenue (ttm)
8.90M
Revenue Growth
-4.34%
P/S Ratio
2.00
Revenue / Employee
247.33K
Employees
36
Market Cap
17.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.22M | 34.00K | 0.37% |
| Dec 31, 2024 | 9.18M | 28.00K | 0.31% |
| Dec 31, 2023 | 9.15M | 970.00K | 11.85% |
| Dec 31, 2022 | 8.18M | 1.37M | 20.14% |
| Dec 31, 2021 | 6.81M | 2.16M | 46.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Global Cord Blood | 196.10M |
| Centogene | 53.65M |
| Bioqual | 42.35M |
| Interpace Biosciences | 36.25M |
| Psychemedics | 19.69M |
| ProPhase Labs | 4.90M |
| Longduoduo Company | 2.13M |
| InVitro International | 811.29K |
Aspira Women's Health News
- 5 hours ago - Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health - Accesswire
- 11 days ago - Aspira Women's Health Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Aspira Women's Health Proxy statement: Proxy filing - Filings
- 4 weeks ago - Aspira Women's Health Proxy statement: Proxy filing - Filings
- 4 weeks ago - Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - Accesswire
- 7 weeks ago - Aspira Women's Health Annual report: Q4 2025 - Filings
- 2 months ago - Aspira Women's Health Slides: Investor presentation - Filings
- 5 months ago - Aspira Women's Health Registration statement: Registration Filing - Filings